SCHWARK; Jan-Robert

Patent Applications and Registrations

Patent applications and USPTO patent grants for SCHWARK; Jan-Robert.The latest application filed is for "use of inhibitors of the cellular na+/h+ exchanger (nhe) for preparing a medicament for normalizing serum lipids".

Company Profile

0.9.7

SCHWARK; Jan-Robert - Kelkheim DE
Schwark, Jan-Robert - Frankfurt DE
Schwark; Jan-Robert - Kelheim DE
Schwark; Jan-Robert - Frankfurt am Main DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Inhibitors Of The Cellular Na+/h+ Exchanger (nhe) For Preparing A Medicament For Normalizing Serum Lipids App 20090143473 - LANG; Hans Jochen ; et al.	2009-06-04
Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them Grant 6,825,231 - Heinelt , et al. November 30, 2	2004-11-30
Use of inhibitors of the cellular Na+/H+ exchanger (NHE) for preparing a medicament for normalizing serum lipids App 20040122096 - Lang, Hans Jochen ; et al.	2004-06-24
Diacyl-substituted guanidines, a process for their preparation, their use as medicament or diagnostic aid, and medicament containing them App 20040044081 - Kleemann, Heinz-Werner ; et al.	2004-03-04
Monoacyl-substituted guanidines, a process for their preparation, their use as a medicament or diagnostic aid, and pharmaceutical compositions containing them Grant 6,632,840 - Kleemann , et al. October 14, 2	2003-10-14
Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them App 20020123529 - Schwark, Jan-Robert ; et al.	2002-09-05
Five-membered heterocycles having biphenylsulfonyl substitution, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them App 20020045761 - Kleemann, Heinz-Werner ; et al.	2002-04-18
Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them App 20010023257 - Heinelt, Uwe ; et al.	2001-09-20
Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them App 20010020042 - Schwark, Jan-Robert ; et al.	2001-09-06
Substituted phenylalkenoylguanidines, process for their preparation, and their use in medicaments and in diagnostics Grant 6,166,002 - Weichert , et al. December 26, 2	2000-12-26
Phenyl.-substituted alkenylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them Grant 6,025,349 - Schwark , et al. February 15, 2	2000-02-15
Substituted benzoylguanidines, process for their preparation, their use as a pharmaceutical as inhibitors of the cellular NA+/H+ exchange or as a diagnostic, and pharmaceutical containing them Grant 5,866,610 - Lang , et al. February 2, 1	1999-02-02
Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them Grant 5,852,046 - Lang , et al. December 22, 1	1998-12-22
Substituted benzyloxycarbonylguanidines, a process for their preparation, their use as a medicament or diagnostic, and a medicament containing them Grant 5,753,710 - Kleemann , et al. May 19, 1	1998-05-19
Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them Grant 5,708,034 - Kleemann , et al. January 13, 1	1998-01-13
Substituted N-heteroaroylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them Grant 5,698,581 - Kleemann , et al. December 16, 1	1997-12-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.